Influenza

The high seasonal morbidity and mortality associated with both pandemic and seasonal influenza, the continued threat of highly pathogenic avian influenza infections, the development and global spread of antiviral resistance, and the [Read more]

The development of anti-influenza drugs has been limited by the fact that animal models do not accurately reflect the infection mechanisms influenza viruses engage in humans. With new funding from the National [Read more]

Seqirus’ accelerated development of its cell-based manufacturing technology has quadrupled influenza vaccine output in just two years, according to a recent statement by the company. The announcement was made on the 10th [Read more]

Scientists have developed a fast and easy-to-use point-of-care diagnostic test that could one day help doctors and hospitals head off the rapid spread of the flu. The gold standard of flu diagnostics [Read more]

UNSEEN ENEMY, about the potential looming crisis of disease pandemics, will debut as a CNN Films broadcast for a World Health Day presentation Friday, April 7 at 9:00pm Eastern on CNN/U.S. UNSEEN [Read more]

A comprehensive review led by academics at The University of Nottingham has found that vaccines are successful in preventing pandemic flu and reducing hospitalizations, but that the effectiveness of vaccines can vary [Read more]

By Rebecca Fish The United States continues to face national security risks from natural, accidental , and intentional health threats. Efforts to improve chemical, biological, radiological and nuclear threats (CBRN) and emerging [Read more]

Fred Hutch virologist Dr. Trevor Bedford and Max Planck physicist and computational biologist Dr. Richard Neher designed a prototype called nextstrain to analyze and track genetic mutations during the Ebola and Zika outbreaks, but they envision it as [Read more]

A Phase 1b multiple ascending dose study to evaluate the safety and tolerability of UV-4B has been initiated by Emergency BioSolutions, according to an announcement by the company on Feb 1. UV-4B [Read more]